Table 1.
Recipient, donor, and transplant characteristics of pediatric kidney transplantation in Iran
| Variable | Statistics |
|---|---|
| Recipient demographic characteristics | |
| Age, mean±SD (range), yrs | 11.1±3.7 (3–18) |
| Age Group (yrs), n (%) | |
| 3–6 | 31 (9.9) |
| 7–10 | 127 (40.5) |
| 11–14 | 89 (28.3) |
| 15–18 | 67 (21.3) |
| Male sex, n (%) | 164 (52.5) |
| Dialysis status before the transplantation, n (%) | |
| Pre-emptive transplantation | 91 (29) |
| Hemodialysis | 199 (63.4) |
| Peritoneal dialysis | 24 (7.6) |
| Dialysis duration before the transplantation (yrs), n (%) | |
| <1 | 74 (33.2) |
| 1–3 | 109 (48.9) |
| >3 | 40 (17.9) |
| Donor characteristics | |
| Age, mean±SD (range), yrs | 34.7±8.3 (15–53) |
| Age group (yrs), n (%) | |
| <20 | 17 (5.4) |
| 20–40 | 253 (80.6) |
| >40 | 44 (14) |
| Male sex, n (%) | 213 (67.8) |
| Type, n (%) | |
| Living related | 42 (13.4) |
| Living unrelated | 251 (79.9) |
| Deceased brain-dead | 21 (6.7) |
| Immunosuppressive regimen, n (%) | |
| Steroid + CSA + AZA | 53 (16.9) |
| Steroid + CSA + MMF | 144 (45.9) |
| Steroid + MMF + TAC | 70 (22.3) |
| Steroid + MMF + SRL | 47 (14.9) |
| Second transplantation, n (%) | 17 (5.4) |
| Acute rejection episode, n (%) | |
| 0 | 224 (71.3) |
| 1 | 78 (24.8) |
| >1 | 12 (3.8) |
| Graft loss, n (%) | 85 (27.1) |
| Malignancy, n (%) | 9 (2.9) |
| Mortality, n (%) | 11 (3.7) |
AZA: azathioprine, CSA: cyclosporine, MMF: mycophenolate mofetil, SRL: sirolimus, TAC: tacrolimus